UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Biopharmaceutical firms' liver treatments draw attention
Local biopharmaceutical companies, including Sillajen, HLB, and Pharmicell,...
by So Jae-hyeon
|
2017-11-30 12:02
라인
Pfizer Korea’s arthritis treatment gets insurance benefits
Pfizer Korea said Thursday that its nonsteroidal anti-inflammatory drug (NS...
by Constance Williams
|
2017-11-30 11:03
라인
FDA setting up new guidelines to boost complex generic drug development
Scott Gottlieb, the commissioner of the U.S. Food and Drug Administration (...
by Lee Han-soo
|
2017-11-30 10:28
라인
‘Healthcare workforce crucial to world development’
John MacArthur, director of the U.S. Centers for Disease Control and Preven...
by Lee Han-soo
|
2017-11-29 16:55
라인
Nanomedicine market to grow rapidly: report
With researchers actively using nanotechnology to treat diseases, the nanom...
by Nam Doo-hyun
|
2017-11-29 16:47
라인
Takeda gets extension for marketing Lymphoma treatment
Takeda Pharmaceuticals Korea announced Tuesday that the European Medicines ...
by Constance Williams
|
2017-11-29 14:58
라인
Novartis Korea mired in sexual harassment scandal
Novartis Korea has been embroiled in a sexual harassment scandal, as a male...
by Park Gi-taek
|
2017-11-29 14:58
라인
‘Weak digital healthcare sector might be eaten by foreign capital’
“Multinational companies are leading the local digital healthcare industry....
by Nam Doo-hyun
|
2017-11-29 14:39
라인
GL PharmTech eyes on new drug development, production
GL PharmTech, a provider of drug formulations and delivery technologies for...
by So Jae-hyeon
|
2017-11-29 11:55
라인
What are doctors’ views on Invossa used even by foreign patients?
An increasing number of patients here are trying to obtain Invossa-K, an os...
by Lee Hye-seon
|
2017-11-29 09:31
라인
[Column] Trauma surgeon Lee, an oddball of lunatic energy
Ajou University Hospital’s regional trauma center officially opened on June...
by Song Hyoung-gon
|
2017-11-29 09:30
라인
Egg freezing becomes new way of choosing time of pregnancy
Women now have more control over when and how they can get pregnant by “fre...
by Marian Chu
|
2017-11-28 17:24
라인
Gynecologists stress need to revise criminal abortion law
As more than 230,000 citizens signed an online petition to repeal the antia...
by Constance Williams
|
2017-11-28 17:14
라인
7 terminally ill patients die under ‘Well-Dying Law’
The Ministry of Health and Welfare said Tuesday that seven terminally-ill p...
by Lee Han-soo
|
2017-11-28 16:28
라인
Pneumonia added to adverse reactions of hepatitis B drug Viread
The government has received reports of adverse drug reactions, including pn...
by Lee Hye-seon
|
2017-11-28 16:07
라인
Korean food not as healthy as you think
With the Hallyu wave and a dictatorship ruled by a lunatic on its doorstep,...
by Constance Williams
|
2017-11-28 15:24
라인
Doctor Lee’s struggle shows downside of medical service in Korea
As a gunshot-wounded North Korean soldier drew the world’s attention for ma...
by Song Soo-youn
|
2017-11-28 15:06
라인
High-frequency resection treats recurrent thyroid cancer
A study has found that radiofrequency ablation, which removes benign “nodul...
by Constance Williams
|
2017-11-28 13:52
라인
Koreans weigh in on what it means to be beautiful: survey
A 2015 survey revealed what Koreans consider beautiful – having the e...
by Marian Chu
|
2017-11-28 12:10
라인
Sanofi begins clinical trial on Hanmi’s diabetes treatment
Hanmi Pharmaceutical said Tuesday that Sanofi would begin to conduct phase ...
by Lee Han-soo
|
2017-11-28 11:05
-
이전
261
262
263
264
265
266
267
268
269
270
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top